In the latest trading session, 1.49 million Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares changed hands as the company’s beta touched 0.87. With the company’s most recent per share price at $13.81 changing hands around $0.18 or 1.36% at last look, the market valuation stands at $3.87B. IOVA’s current price is a discount, trading about -32.73% off its 52-week high of $18.33. The share price had its 52-week low at $3.21, which suggests the last value was 76.76% up since then. When we look at Iovance Biotherapeutics Inc’s average trading volume, we note the 3-month average coming to 8.84 million.
Iovance Biotherapeutics Inc (NASDAQ:IOVA) trade information
Instantly IOVA is in green as seen in intraday trades today. With action 14.84%, the performance over the past five days has been green. The jump to weekly highs of 14.23 added 1.36% to the stock’s daily price. The company’s shares are showing year-to-date upside of 69.93%, with the 5-day performance at 14.84% in the green. However, in the 30-day time frame, Iovance Biotherapeutics Inc (NASDAQ:IOVA) is 2.11% up.
Iovance Biotherapeutics Inc (IOVA) estimates and forecasts
Data shows that the Iovance Biotherapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 256.06% over the past 6 months, a 25.40% in annual growth rate that is considerably higher than the industry average of 13.00%. Year-over-year growth is forecast to reach 13,977.40% up from the last financial year.
Consensus estimates given by 12 financial analysts project the company’s revenue in the current quarter to hit an average of 2.07M. 12 analysts are of the opinion that Iovance Biotherapeutics Inc’s revenue for the current quarter will be 30.43M. The company’s revenue for the corresponding quarters a year ago was 200k and 238k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 935.00%. The estimates for the next quarter sales put growth at 12,685.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.25%. The 2024 estimates are for Iovance Biotherapeutics Inc earnings to increase by 31.49%.
